Harold Varmus, M.D.
Director, NIH
April, 1999

The complete report is available in one PDF file (67 K), which is ideal for printing and reading off-line. Information on Adobe's PDF file is also available.

EXECUTIVE SUMMARY

INTRODUCTION

BACKGROUND

Treatment of Hemophilia and Other Bleeding Disorders

Improvements in Blood Safety

Complications of Hemophilia

Complications of Other Bleeding Disorders

Finding a Cure

RESEARCH ON COMPLICATIONS OF HEMOPHILIA

Mechanisms of Bleeding and Clotting

Antibody/Inhibitor Formation

Gene Therapy for Hemophilia

Blood-Borne Infectious Agents

• Human Immunodeficiency Virus (HIV)
  Hepatitis C Virus (HCV)

Blood Safety

• HIV and Hepatitis
  Creutzfeldt-JakobDisease(CJD)

Behavioral Research

MONITORING THE BLOOD SUPPLY

COORDINATING COMMITTEES

Public Health Service (PHS) Blood Safety Committee

DHHS Advisory Committee on Blood Safety and Availability (ACBSA)

Trans-Angency Hepatitis Working Group

Trans-NIH Hepatitis C Virus Working Group

Other Coordinating Groups

CONCLUSION

8/31/99